Return to homepagePandemic Pact

Impact on Patients of Changes in Provision of Methadone During the COVID-19 Pandemic: A Pilot Study

Grant number: unknown

Grant search

Key facts

  • Disease

    COVID-19

  • Start & end year

    2020
    2021

  • Known Financial Commitments (USD)

    $86,250

  • Funder

    FORE

  • Principal Investigator

    MD. Ayana Jordan

  • Research Location

    United States of America

  • Lead Research Institution

    Yale University

  • Research Priority Alignment

    N/A

  • Research Category

    Secondary impacts of disease, response & control measures

  • Research Subcategory

    Indirect health impacts

  • Special Interest Tags

    N/A

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Adults (18 and older)

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

Researchers at Yale University School of Medicine will survey 500 patients in six states who received take-home doses of methadone for opioid use disorder after the federal government relaxed its restrictions on opioid treatment programs in response to the pandemic. In addition to eliciting information about patients' experiences, the study will inform future policy by assessing whether the use of take-home doses has varied among subpopulations and whether the practice is associated with increases in accidental overdoses, medication diversion, or misuse.